TLPH
Price:
$1.2693
Market Cap:
$26.04M
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was former...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-02-11
Stock Exchange
NASDAQ
Ticker
TLPH
According to Talphera, Inc.’s latest financial reports and current stock price. The company's current ROE is -151.40%. This represents a change of 285.46% compared to the average of -39.28% of the last 4 quarters.
The mean historical ROE of Talphera, Inc. over the last ten years is -0.78%. The current -151.40% ROE has changed 19.19% with respect to the historical average. Over the past ten years (40 quarters), TLPH's ROE was at its highest in in the June 2022 quarter at 213.21%. The ROE was at its lowest in in the September 2016 quarter at -348.47%.
Average
-0.78%
Median
85.11%
Minimum
-1108.61%
Maximum
808.64%
Discovering the peaks and valleys of Talphera, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 123.87%
Maximum Annual ROE = 808.64%
Minimum Annual Increase = -1197.44%
Minimum Annual ROE = -1108.61%
| Year | ROE | Change |
|---|---|---|
| 2024 | -162.53% | 24.61% |
| 2023 | -130.43% | -159.58% |
| 2022 | 218.92% | 123.87% |
| 2021 | 97.79% | 35.01% |
| 2020 | 72.43% | -43.65% |
| 2019 | 128.54% | -111.60% |
| 2018 | -1108.61% | -885.78% |
| 2017 | 141.08% | -82.55% |
| 2016 | 808.64% | -1197.44% |
| 2015 | -73.68% | 3.07% |
The current ROE of Talphera, Inc. (TLPH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-24.68%
5-year avg
19.24%
10-year avg
-0.78%
Talphera, Inc.’s ROE is greater than SCYNEXIS, Inc. (-37.42%), greater than Apimeds Pharmaceuticals US, Inc (-266.22%), greater than MIRA Pharmaceuticals, Inc. (-406.68%), greater than Nutriband Inc. (-131.40%), greater than iBio, Inc. (-83.61%), greater than Cosmos Health Inc. (-74.28%), less than Iterum Therapeutics plc (602.38%), greater than P3 Health Partners Inc. (-409.55%), greater than Intensity Therapeutics, Inc. (-370.86%), greater than Retractable Technologies, Inc. (-8.13%),
| Company | ROE | Market cap |
|---|---|---|
| -37.42% | $27.75M | |
| -266.22% | $27.04M | |
| -406.68% | $62.17M | |
| -131.40% | $55.69M | |
| -83.61% | $20.33M | |
| -74.28% | $13.30M | |
| 602.38% | $24.42M | |
| -409.55% | $17.16M | |
| -370.86% | $24.06M | |
| -8.13% | $24.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Talphera, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Talphera, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Talphera, Inc.'s ROE?
How is the ROE calculated for Talphera, Inc. (TLPH)?
What is the highest ROE for Talphera, Inc. (TLPH)?
What is the 3-year average ROE for Talphera, Inc. (TLPH)?
What is the 5-year average ROE for Talphera, Inc. (TLPH)?
How does the current ROE for Talphera, Inc. (TLPH) compare to its historical average?